Haemonetics Corp

Ownership Transactions Reported by 22 Insiders

Symbol
HAE on NYSE
Location
125 Summer Street, Boston, Massachusetts

Insiders trading volume in the past year

Haemonetics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Simon President & CEO, Director $31.7 M Jun 6, 2024
Josep Llorens EVP, Global Manufacturing $2.96 M -$689 K -18.9% May 28, 2024
Michelle L. Basil EVP and General Counsel $2.77 M -$1.49 M -35% May 28, 2024
William Burke EVP, Chief Financial Officer $2.62 M Aug 23, 2021
Anila Lingamneni EVP, Chief Technology Officer $2.25 M -$426 K -15.9% May 28, 2024
Charles J. Dockendorff Director $1.74 M -$896 K -34% Sep 5, 2023
Robert E. Abernathy Director $1.73 M Aug 4, 2023
Laurie A. Miller SVP, Human Resources $1.73 M May 28, 2024
Catherine M. Burzik Director $1.69 M Aug 5, 2022
James DArecca EVP, Chief Financial Officer $1.66 M May 17, 2024
Mark W. Kroll Director $1.59 M Aug 4, 2023
Stewart W. Strong President, Global Hospital $1.59 M -$932 K -36.9% May 28, 2024
Chad M. Nikel President, Global Plasma & BC $1.5 M Aug 6, 2021
Ellen M. Zane Director $1.25 M Aug 4, 2023
Claire Pomeroy Director $1.03 M Aug 4, 2023
Michael J. Coyle Director $907 K Aug 4, 2023
Roy Galvin President, Global Plasma & BC $705 K May 17, 2024
Lloyd E. Johnson Director $694 K Aug 4, 2023
Dan Goldstein VP, Corporate Controller $384 K Jun 13, 2022
Jacqueline Scanlan SVP, Global Human Resources $364 K Jun 7, 2021
Diane M. Bryant Director $192 K Aug 4, 2023
Farris Maryanne Maunsell VP, Chief Accounting Officer $109 K May 17, 2024

Recent Insider Transactions by Companies or Individuals for Haemonetics Corp

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership